MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Insight Molecular Diagnostics (IMDX) Ownership - Who owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
175.01M
P/E Ratio
N/A
Total Cash
28.2M
Projected Growth
N/A
Total Debt
3.07M
Revenue
1.95M
Risk (Beta)
2.46
Dividend Yield
N/A
Total Cash/Share
0.87
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMDX
A.I. Advisor
published General Information

General Information

a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer

Industry MedicalSpecialties

Profile
Details
Industry
Medical Specialties
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A